Qualigen Therapeutics and BitGo Collaborate on Multi-Asset C10 Treasury Allocation

ago 3 hours
Qualigen Therapeutics and BitGo Collaborate on Multi-Asset C10 Treasury Allocation

On October 23, 2025, Qualigen Therapeutics Inc. (NASDAQ: QLGN) announced a new strategic collaboration with BitGo, a leading digital asset infrastructure company. This partnership aims to enhance Qualigen’s C10 treasury strategy, which focuses on accumulating a market-cap-weighted selection of the top 10 cryptocurrency assets, excluding stablecoins.

Qualigen and BitGo Partnership Details

Through this collaboration, Qualigen will utilize BitGo’s comprehensive treasury management services. This includes access to significant liquidity and secure qualified custody for its digital assets. The arrangement allows Qualigen to effectively invest in a diversified portfolio of cryptocurrencies.

Key Features of the Partnership

  • Qualigen’s treasury assets will be held in secure, regulated cold storage by BitGo.
  • The partnership emphasizes compliance with the highest security standards.
  • BitGo’s expertise spans over a decade in digital asset management.

Jerry Wang, Co-CEO of Qualigen, expressed enthusiasm for the partnership, highlighting it as a step towards diversifying the company’s corporate treasury with digital assets. He emphasized Qualigen’s commitment to financial resilience and its leadership role in the evolving digital economy.

Similarly, Mike Belshe, CEO of BitGo, noted that the $30 million multi-asset allocation reflects growing enterprise confidence in adopting a digital-first treasury strategy. He reaffirmed BitGo’s dedication to providing secure infrastructure and liquidity for this initiative.

The Significance of the Collaboration

This partnership underscores a notable trend: the convergence of advanced technology and digital finance. Qualigen is positioning itself as a pioneering technology innovator committed to integrating a diversified digital asset treasury strategy.

About Qualigen Therapeutics

Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California. The biotechnology company focuses on developing innovative therapeutics in oncology and immunology. It is actively integrating cryptocurrency and web3 initiatives to facilitate global growth.

About BitGo

Founded in 2013, BitGo specializes in digital asset infrastructure, offering custody, wallets, staking, trading, financing, and settlement services from regulated cold storage. It serves numerous institutions and supports the global transition to a digital asset economy.

This collaboration represents a significant milestone in both companies’ journeys, potentially transforming how treasury strategies are conducted in the digital landscape of finance.